Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/03/2012US8211429 Neuropilin antagonists
07/03/2012CA2665567C Stable formulations
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2441595C Proteins producing an altered immunogenic response and methods of making and using the same
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2403001C Modulating production of pneumococcal capsular polysaccharide
07/03/2012CA2397610C In vivo assay for testing the phenotypic stability
07/03/2012CA2330618C Viral chimeras comprised of caev and hiv-1 genetic elements
07/03/2012CA2318052C Antibodies against human il-12
07/03/2012CA2305269C Treatment of neoplasms with viruses
07/03/2012CA2196555C Vr-2332 viral nucleotide sequence and methods of use
06/2012
06/28/2012WO2012088473A1 Alphavirus compositions and methods of use
06/28/2012WO2012088428A1 Modified influenza hemagglutinin proteins and uses thereof
06/28/2012WO2012088414A1 Liposomal formulation of nonglycosidic ceramides and uses thereof
06/28/2012WO2012088388A2 Treating multiple myeloma
06/28/2012WO2012088313A1 Anti-pcsk9 antibodies and methods of use
06/28/2012WO2012088305A1 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
06/28/2012WO2012088302A2 Half immunoglobulin binding proteins and uses thereof
06/28/2012WO2012088290A2 Tri-variable domain binding proteins and uses thereof
06/28/2012WO2012088272A1 Methods and compositions combining immunotherapy with monocyte activation
06/28/2012WO2012088265A1 Anti-p-selectin antibodies and methods of their use and identification
06/28/2012WO2012088247A2 Anti-c5/c5a/c5adesr antibodies and fragments
06/28/2012WO2012088210A2 Methods and compositions for wound treatment
06/28/2012WO2012088125A2 Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis
06/28/2012WO2012088094A2 Il-1 binding proteins
06/28/2012WO2012088041A1 Adenoviral vector-based dengue fever vaccine
06/28/2012WO2012088001A2 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus
06/28/2012WO2012087962A2 Anti-mesothelin antibodies and immunoconjugates
06/28/2012WO2012087746A1 Active protease-resistant antibody fc mutants
06/28/2012WO2012087483A1 Recombinant bacterium comprising a toxin/antitoxin system
06/28/2012WO2012085872A2 Stable immunogenic compositions of staphylococcus aureus antigens
06/28/2012WO2012085642A1 Vaccines with live bacterial isolates for systemic administration
06/28/2012WO2012085603A2 Dna sensors
06/28/2012WO2012085183A1 Novel bacterium and extracts of said bacterium and the use of same in therapy
06/28/2012WO2012085132A1 Antibodies against human cd39 and use thereof
06/28/2012WO2012085111A1 Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
06/28/2012WO2012085101A1 Recombinant mycobacterium as a vaccine
06/28/2012WO2012085099A1 Determination of the efficacy of an anti-mycobacterial vaccination
06/28/2012WO2012085090A1 Vaccines based on peptides of the complement protein c5a
06/28/2012WO2012085072A1 Gas-filled microvesicles for use as vaccine
06/28/2012WO2012084951A1 Enhanced immune response in bovine species
06/28/2012WO2012084272A1 Oprf/i agents and their use in hospitalized and other patients
06/28/2012WO2012083837A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
06/28/2012WO2012083445A1 Virus like particle production in plants
06/28/2012WO2012083382A1 Conjugates of acyl homoserine lactone and catalase a from pseudomonas aeruginosa
06/28/2012WO2012083370A1 Modified antibody with improved half-life
06/28/2012WO2012061811A3 Anti- connective tissue growth factor agent for use in the treatment of lung remodeling disease
06/28/2012WO2012061289A9 Methods for treatment of brain injury utilizing biologics
06/28/2012WO2012061239A3 Novel vaccines against pandemic influenza virus a/h1n1
06/28/2012WO2012058957A3 Polysaccharide extracts of epimedium, fractions thereof and uses thereof in vaccine adjuvants
06/28/2012WO2012058768A8 Stable heterodimeric antibody design with mutations in the fc domain
06/28/2012WO2012055986A9 Methods for capturing virus like particles from plants using expanded bed chromatography
06/28/2012WO2012054717A3 Detecting and treating solid tumors through selective disruption of tumor vasculature
06/28/2012WO2012053828A9 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
06/28/2012WO2012051282A3 Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy
06/28/2012WO2012047339A9 Anti-cxcr4 as a sensitizer to cancer therapeutics
06/28/2012WO2012045063A3 Flavivirus domain iii vaccine
06/28/2012WO2012038812A3 Top2a inhibition by temozolomide useful for predicting gbm patient's survival
06/28/2012WO2012036391A3 Surface expression vector of porcine circovirus type 2 (pcv2) gene and salmonella vaccine strain transformed with same
06/28/2012WO2012033328A3 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
06/28/2012WO2012024519A4 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
06/28/2012WO2011153351A3 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
06/28/2012WO2011146568A8 Predicting response to a her inhibitor
06/28/2012WO2011133685A9 Nanoparticle targeting to ischemia for imaging and therapy
06/28/2012WO2010039223A3 T-cell immunogens derived from anti-viral proteins and methods of using same
06/28/2012US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
06/28/2012US20120164629 Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
06/28/2012US20120164189 Lipidic Compositions for Induction of Immune Tolerance
06/28/2012US20120164183 Method for detection and treatment of aneurysms
06/28/2012US20120164180 Cancer Vaccines and Therapeutic Methods
06/28/2012US20120164179 Leishmania Challenge Model
06/28/2012US20120164178 Vaccine
06/28/2012US20120164177 Rhinovirus vaccines
06/28/2012US20120164176 Rsv f protein compositions amd methods for making same
06/28/2012US20120164175 Novel influenza virus
06/28/2012US20120164174 Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
06/28/2012US20120164173 Papilloma Pseudovirus and Preparation
06/28/2012US20120164172 Cancer Therapy
06/28/2012US20120164171 Antiviral Activity of Bovine Type III Interferon Against Foot-and-Mouth Disease Virus
06/28/2012US20120164170 Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof
06/28/2012US20120164169 Bovine herpesvirus vaccine
06/28/2012US20120164168 B7-dc variants immunogenic compositions and methods of use thereof
06/28/2012US20120164167 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals
06/28/2012US20120164164 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
06/28/2012US20120164163 Cdc45l peptides and vaccines including the same
06/28/2012US20120164162 Methods in cell cultures, and related inventions, employing certain additives
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164160 Monoclonal antibodies against claudin-18 for treatment of cancer
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164158 Anti-ADDL Monoclonal Antibody and Use Thereof
06/28/2012US20120164157 Method of treating stroke with thrombolytic agent
06/28/2012US20120164156 Recombinant F1-V Plague Vaccine
06/28/2012US20120164155 Chimeric molecules
06/28/2012US20120164154 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes
06/28/2012US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 1823